Singapore Sinovac: Everything You Need to Know
If you live in Singapore and have been following the news, you may have heard about Sinovac, a COVID-19 vaccine that has been included in the country’s National Vaccination Programme. Perhaps you have questions about the vaccine’s efficacy or how to get vaccinated with Sinovac. In this article, we will explore the topic of Singapore Sinovac and answer some frequently asked questions.

Sinovac is a vaccine developed by a Chinese biopharmaceutical company. It is an inactivated virus vaccine that stimulates the body to produce protection against the actual COVID-19 virus. Sinovac has been included under Singapore’s National Vaccination Programme until September 30, 2024. Individuals who have taken the Sinovac-CoronaVac vaccine for their first two doses can now walk into certain vaccination centres without an appointment for their third dose.
If you are interested in learning more about Singapore Sinovac, keep reading. We will discuss the vaccine’s role in the vaccination programme, its efficacy, and answer some frequently asked questions.
Key Takeaways
- Sinovac is a COVID-19 vaccine included in Singapore’s National Vaccination Programme.
- Individuals who have taken the Sinovac-CoronaVac vaccine for their first two doses can now walk into certain vaccination centres without an appointment for their third dose.
- Sinovac is an inactivated virus vaccine that stimulates the body to produce protection against the actual COVID-19 virus.
Vaccination Programme in Singapore

National Vaccination Programme
The National Vaccination Programme in Singapore aims to provide access to COVID-19 vaccines to all Singaporean citizens, Permanent Residents, Long Term Pass Holders and Short Term Pass Holders. The programme includes the Sinovac-CoronaVac COVID-19 vaccine, which has been authorized by the Health Sciences Authority.
Vaccination Centres and Registration
Vaccination centres are available across Singapore for individuals to receive their COVID-19 vaccination. You can register for your vaccination appointment via the National Appointment System or through the respective vaccination centres.
Special Access Route and Emergency Use
In addition to the National Vaccination Programme, there is a Special Access Route for individuals who require early access to the Sinovac-CoronaVac vaccine. This route is only available for individuals who meet specific criteria, such as those who need to travel overseas for work or study.
In emergency situations, the Sinovac-CoronaVac vaccine may also be used under the Emergency Use Listing. This allows for the use of the vaccine in situations where there is a public health emergency.
Overall, the Singaporean government has taken a proactive approach to ensure access to COVID-19 vaccines for all individuals in Singapore. The National Vaccination Programme, along with the Special Access Route and Emergency Use Listing, provide options for individuals to receive their COVID-19 vaccination.
Sinovac’s Role and Efficacy

Sinovac-CoronaVac and Sinopharm
Sinovac is a Chinese biopharmaceutical company that has developed the Sinovac-CoronaVac vaccine. The vaccine is an inactivated virus COVID-19 vaccine that stimulates the body to produce protection against the actual COVID-19 virus. The Sinopharm vaccine is also an inactivated virus vaccine developed by another Chinese company.
Vaccine Effectiveness and Protection
According to studies, the Sinovac-CoronaVac vaccine has an efficacy rate of 51% for symptomatic COVID-19. However, it has been shown to be effective in preventing severe disease, hospitalization, and death. As at May this year, Sinovac demonstrated vaccine effectiveness of 66% against the Alpha and Gamma variants.
Safety and Medically Ineligible Individuals
The Health Sciences Authority (HSA) has granted interim authorisation for the Sinovac-CoronaVac vaccine in Singapore. The Expert Committee on COVID-19 Vaccination has independently reviewed the vaccine’s safety and efficacy data for different population segments in Singapore. The committee has recommended that medically ineligible individuals, such as those with a history of severe allergic reaction or severe disease, should not receive the vaccine.
Allergic Reaction
Individuals who have experienced a severe allergic reaction to any component of the Sinovac-CoronaVac vaccine should not receive the vaccine. Those who have had a mild or moderate reaction to the vaccine should consult their doctor before receiving the second dose.
Conclusion
In conclusion, the Sinovac-CoronaVac vaccine has been included in the Singapore national vaccination programme. Although its efficacy rate is lower than mRNA vaccines, it has been shown to be effective in preventing severe disease, hospitalization, and death. The vaccine is safe for most individuals, but medically ineligible individuals should not receive the vaccine.
Frequently Asked Questions

Where can I find clinics offering the Sinovac vaccine in Singapore?
If you are interested in receiving the Sinovac vaccine in Singapore, you can do so at selected participating General Practitioner (GP) clinics offering the vaccine. It is recommended that you call the clinic beforehand to make an appointment.
Am I eligible for a Sinovac booster shot in Singapore, and if so, how do I get one?
At the moment, there is no information available on whether Sinovac booster shots will be made available in Singapore. However, you can check with your healthcare provider or the Ministry of Health for any updates.
What does being fully vaccinated mean in Singapore’s context?
In Singapore, you are considered fully vaccinated against COVID-19 if you have received two doses of the Pfizer-BioNTech or Moderna vaccine, or one dose of the Johnson & Johnson vaccine. If you have received the Sinovac vaccine, you will need to take an additional dose of either Pfizer-BioNTech or Moderna vaccine to be considered fully vaccinated.
Are there any provisions for foreigners to receive the COVID vaccine in Singapore?
Yes, foreigners who are living or working in Singapore are eligible to receive the COVID-19 vaccine. You can check with your healthcare provider or the Ministry of Health for more information on how to get vaccinated.
How does the Sinovac vaccine compare to Pfizer in terms of efficacy?
According to the Ministry of Health, the Sinovac vaccine has an efficacy rate of 51% against symptomatic COVID-19 infection, while the Pfizer-BioNTech vaccine has an efficacy rate of 95% against symptomatic COVID-19 infection. However, it is important to note that both vaccines have been shown to be effective in preventing severe illness and hospitalization.
What are the safety considerations when opting for the Sinovac vaccine?
Like all vaccines, the Sinovac vaccine may cause side effects such as pain at the injection site, fever, and fatigue. However, serious side effects are rare. It is important to discuss any concerns you may have with your healthcare provider before getting vaccinated.